Immunoassay screen for the following drug classes or method groups: barbiturates, cannabinoids, cocaine, and ethanol. Test also includes specimen validity testing (creatinine, pH, and oxidants) to detect adulteration, dilution, or substitution of the specimen.
Results of this test are presumptive. If confirmatory testing is desired, the confirmatory test(s) can be ordered as add-on (u-have) tests, utilizing the original urine collection, within 9 days of the original test.
This test is intended to compliment the test “Targeted Drug Panel, Urine” (TDPU).
NOTE: This test is only for internal use only. It is active in the Lab System only – and will need to be manually entered via LOM if needed.
PD-L1, PDL1, 22C3, KEYTRUDA, pembrolizumab, IHC, Immunohistochemistry
-13/13q-, RB1/LAMP1 t(11;14) CCND1/IGH 14q32 rearrangement, IGH 17p-, TP53/D17Z1 +3/+7, D3Z1/D7Z1 +9/+15, D9Z1/D15Z4 1q gain, TP73/CKS1B 8q24.1 rearrangement, MYC
When an IGH rearrangement is identified, reflex testing is performed to identify the translocation partner. Probes include identification of t(4;14)(p16.3;q32) FGFR3/IGH, t(14;16)(q32;q23) IGH/MAF, t(14;20)(q32;q12), IGH/MAFB or t(6;14)(p21;q32) CCND3/IGH.
This test includes a charge for application of the first probe set (2 FISH probes) and professional interpretation of results. Additional charges will be incurred for all reflex probes performed. Analysis charges will be incurred based on the number of cells analyzed per probe set. If no cells are available for analysis, no analysis charges will be incurred.
Indicate if the entire panel is to be performed. If the patient is being tracked for known abnormalities, indicate which probes should be used.
PLM, PLM6S, Platelet Mapping
HKH-MA, ActFMA, ADP-MA, %INH-ADP, %AGG-ADP
Special Note: Patient must be off of Coumadin for three weeks to order this test as Coumadin will lower Protein C Antigen level. If on Coumadin, order PROT-CM.
Protein C Immunologic